Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899180 · ClinicalTrials.gov registry record · Early Phase 1
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
A Early Phase 1 study of Aortic Stenosis and Transthyretin Amyloidosis, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT04899180 is a Early Phase 1 study of Aortic Stenosis and Transthyretin Amyloidosis that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04899180, a Early Phase 1 study of Aortic Stenosis and Transthyretin Amyloidosis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the prevalence of transthyretin cardiac amyloidosis (TTR-CA) among patients with moderate and severe aortic stenosis in Southeast Minnesota using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT).
Conditions Studied
Interventions
- DRUG 99mTc-PYP
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2024-01-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04899180
The ClinicalTrials.gov registry entry for NCT04899180 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,362-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which 99mTc-PYP is the first listed.
NCT04899180 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04899180 about?
NCT04899180 is a clinical study titled "Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis". The purpose of this study is to determine the prevalence of transthyretin cardiac amyloidosis (TTR-CA) among patients with moderate and severe aortic stenosis in Southeast Minnesota using 99mTc-PYP single-photon positive emission computed tomography with computed tomography (SPECT/CT).
What is the current status of trial NCT04899180?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2023-07-14. Estimated completion is 2024-01-05.
What conditions does trial NCT04899180 study?
This clinical trial studies the following conditions: Aortic Stenosis, Transthyretin Amyloidosis, Transthyretin Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy.
What interventions are being tested in trial NCT04899180?
The interventions under investigation include: 99mTc-PYP (DRUG).
Who is sponsoring clinical trial NCT04899180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04899180 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Loss of Y Chromosome in Aortic Stenosis
RECRUITING
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RECRUITING · Phase 2
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Comparative Imaging Assessment of Valvular Heart Disease
RECRUITING
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.